A carregar...
Chimeric Antigen Receptor (CAR)-Engineered Lymphocytes for Cancer Therapy
INTRODUCTION: Chimeric antigen receptors (CARs) usually combine the antigen binding site of a monoclonal antibody with the signal activating machinery of a T cell, freeing antigen recognition from major histocompatibility complex restriction and thus breaking one of the barriers to more widespread a...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3107373/ https://ncbi.nlm.nih.gov/pubmed/21463133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2011.573476 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|